Novo Nordisk
Helene Lykkegaard has extensive experience in molecular biology and cell culture techniques, primarily serving as a Principal Technician at Novo Nordisk since December 2010. Expertise includes HCS Imaging, Flow Cytometry, MSD, ELISA, RNA, and qPCR, with a focus on liver biology, microphysiological systems, and advanced cell assays. Previous roles include Senior Technician positions at Mirrx Therapeutics A/S and LiPlasome Pharma A/S, where work involved miRNA inhibition and liposome-encapsulated therapeutics, respectively. Earlier career experience includes a Technician role at Pharmexa A/S and LEO Pharma, focusing on receptor-binding assays and maintaining mammalian cell lines. Helene holds multiple degrees in cell biology, toxicology, immunology, and PCR techniques from Professionshøjskolen Metropol, alongside a foundational education in laboratory work from Roskilde.
This person is not in any teams
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.